InvestorsHub Logo

CherryTree1

06/29/21 6:15 PM

#387039 RE: JerryCampbell #387034

This is a quote from Linda at the ASM May 18 2021.

Once we have the initial license, then we expect to begin producing vaccine products for our existing programs as we've been doing at the small facility in London that we've been using up 'til now.

Doc logic

06/29/21 6:27 PM

#387044 RE: JerryCampbell #387034

Jerry Campbell,

See CherryTree1’s post and be reconciled to the fact that once Charles Rivers Labs and Sawston are on line, and I expect Charles Rivers Labs to beat Sawston but only act as a backup initially, that a backlog of demand will quickly develop. There is a waiting list now and Dr. Ashkan is quoted as saying he wants this treatment for All of his patients. Dr. Ashkan is very well respected not only in the UK but throughout Europe. Medical tourism is also possible in some limited form. Best wishes.